RT 100% Strategy (@StrategyMaxi)JPMorgan messed with the wrong man. 💀It's Saylor.Instead of working with Strategy, they attacked him.Saylor played a reverse UNO:- Bombshell Epstein connections among JPMorgan executives- Mobilizing retail to strike back- HODL BTC to short squeezeStand with Saylor! https://t.co/lyYRiblHvG ...

Core Viewpoint - JPMorgan has a bullish outlook for the S&P 500, forecasting it to reach 7,500 by the end of 2026, with potential to exceed 8,000 if the Federal Reserve implements aggressive rate cuts, indicating an 18% rally from the current closing value of 6,765 [1][4]. Economic Drivers - Key drivers of market momentum include resilient economic growth, accelerated technological investment, and favorable policy conditions [3]. - The adoption of artificial intelligence is leading to record corporate capital expenditure, alongside rising shareholder distributions and supportive fiscal measures [3][5]. Earnings Projections - JPMorgan projects U.S. corporate earnings to grow by 13–15% over the next two years, which supports their baseline target of 7,500 and the potential for exceeding 8,000 under aggressive monetary easing scenarios [4][6]. Valuation Justification - Elevated valuations in technology and AI-driven sectors are considered justified due to expected productivity gains, structural market shifts, and increasing shareholder returns [5]. Market Sentiment - Other Wall Street analysts maintain a slightly more conservative yet optimistic stance, with Oppenheimer Asset Management raising its year-end target to 7,100 and UBS Global Research projecting a 2026 year-end level of 7,500 [7][8].

Core Viewpoint - JPMorgan's equity strategy team predicts a strong performance for US investors in 2026, with a year-end price target of 7,500 for the S&P 500, potentially exceeding 8,000 if the Federal Reserve continues to cut interest rates [1][3]. Group 1: Earnings Growth and Economic Outlook - The forecast for the S&P 500 reaching 7,500 is supported by expected earnings growth of 13% to 15% over the next two years, with a reported 13.4% earnings growth in the third quarter for S&P 500 companies [2]. - The firm anticipates the Federal Reserve will cut rates two more times, with an 85% market expectation for a rate cut next month, which could lead to an improved inflation outlook and further rate cuts [3]. Group 2: Market Sentiment and Economic Dynamics - The US economy is described as increasingly K-shaped, indicating a widening gap between different income groups, which is reshaping consumer spending habits and confidence [4][5]. - This economic backdrop is expected to create volatility in market sentiment, contrasting the struggles of lower-income consumers with the spending behavior of wealthier individuals who are more exposed to the stock market [6]. Group 3: AI Investment Trends - Corporates and governments globally are racing to invest in AI to enhance productivity and avoid obsolescence, which is seen as a significant trend influencing market dynamics [7].

智通财经APP获悉，香港联交所最新数据显示，11月21日，摩根大通增持药明康德(02359)73.6509万 股，每股作价102.4881港元，总金额约为7548.34万港元。增持后最新持股数目约为2572.02万股，持股 比例为5.03%。 ...

Core Viewpoint - Morgan Stanley has significantly raised its target for the S&P 500 index, predicting it will reach 7500 points by the end of 2026, driven by strong corporate earnings growth and an AI capital investment boom [1][4]. Group 1: Market Outlook - The S&P 500 index is expected to rise approximately 11% from its recent closing price of 6765.88 points, surpassing the average forecast of 7269 points from Bloomberg-tracked strategists [1][4]. - In a more optimistic scenario, if the Federal Reserve's monetary policy is more accommodative than expected, the S&P 500 could potentially exceed 8000 points next year [4]. Group 2: Corporate Earnings - Strong corporate earnings are a key pillar of Morgan Stanley's bullish outlook, with expectations of 13% to 15% growth in earnings over the next two years [4]. - The report suggests that current high valuations are justified by above-trend earnings growth expectations, increased AI capital expenditures, and enhanced shareholder returns [5]. Group 3: Broader Market Sentiment - Other Wall Street analysts share a bullish sentiment, with some projecting the S&P 500 could rise to as high as 7800 points, citing a favorable environment for risk assets due to a combination of fiscal, monetary, and regulatory policies [6]. - Analysts from various firms, including Barclays and Macro Risk Advisors, have set significant milestones for the S&P 500, indicating a strong upward trajectory in the near term [6].

Group 1 - Morgan Stanley increased its stake in Sunny Optical Technology (02382) by 1.764 million shares at a price of HKD 62.661 per share, totaling approximately HKD 111 million [1] - After the increase, Morgan Stanley's total shareholding in Sunny Optical is approximately 55.8073 million shares, representing a holding percentage of 5.09% [1]

智通财经APP获悉，香港联交所最新数据显示，11月21日，摩根大通增持药明康德(02359)73.6509万 股，每股作价102.4881港元，总金额约为7548.34万港元。增持后最新持股数目约为2572.02万股，持股 比例为5.03%。 ...

智通财经APP获悉，香港联交所最新数据显示，11月21日，摩根大通增持舜宇光学科技(02382)176.3995 万股，每股作价62.661港元，总金额约为1.11亿港元。增持后最新持股数目约为5580.73万股，持股比例 为5.09%。 ...

香港联交所最新数据显示，11月21日，摩根大通增持宁德时代（300750）(03750)68.3542万股，每股作 价465.0978港元，总金额约为3.18亿港元。增持后最新持股数目约为1115.12万股，持股比例为7.15%。 ...

Group 1 - Morgan Stanley increased its stake in China National Pharmaceutical Group (01099) by 2,104,841 shares at a price of HKD 20.1147 per share, totaling approximately HKD 42.3382 million [1] - After the increase, the total number of shares held by Morgan Stanley is approximately 67,182,200, representing a holding percentage of 5% [1]